AHR and obesity disorder: ox-LDL can activate TLR2/4 signaling cascades that ultimately provide high levels of activated IDO1, which in turn produce excess kynurenine from the available tryptophan, thereby upregulating AHR signaling in hepatocytes and leading to obesity and associated diseases [181].